Dangerous Side Effects of TDF Cause Harm to Unknowing Patients

TDF HIV Drugs

Gilead Sciences, Inc., a commercial pharmaceutical manufacturer, is facing hundreds of lawsuits and accusations of negligence and fraud related to its HIV medication. Many patients claim the HIV medication tenofovir disoproxil fumarate (TDF) has caused kidney disease and bone density loss.

Drugs with the brand names Truvada, Viread, Atripla, Stribild, and Complera contain TDF as the main ingredient. These drugs are supposed to help patients by keeping the HIV virus from multiplying. Instead of helping people though, the drugs have caused individuals to suffer severe complications in the kidneys and damage to the bones.

Not only did Gilead Sciences not warn consumers about the harmful side effects of TDF, but they continued to produce it and profit from it. The company also produced a drug called tenofovir alafenamide fumarate (TAF). TAF was more effective at stopping HIV from multiplying and also did not pose the same dangerous side effects as TDF. However, it is believed and alleged that Gilead Sciences wanted to keep selling TDF until the patent ran out before releasing its safer alternative, TAF.

When companies put profits over the safety of consumers, they need to be held accountable. The attorneys at Baron & Budd are here to help, and will work hard to hold them accountable for their unethical and negligent behavior.

Contact Baron & Budd

If you are thinking of taking action against Gilead, the attorneys at Baron & Budd can help you. Baron & Budd has a long track record of success in cases such as these. If you or someone you know took a medication containing TDF and developed kidney disease or bone density loss afterward, we may be able to help. Please call 866-723-1890 or contact us online to learn more.

  • Get Answers Now

    Get a free case evaluation to help determine your legal rights.

  • Receive emails from Baron & Budd?
  • Receive text messages from Baron & Budd?
  • This field is for validation purposes and should be left unchanged.